• For Researchers

Entering new worlds: the dual role of clinical academics

We recognise the value in bringing clinical skills and perspectives into the research world, and we support clinicians to launch and progress research careers. We recognise the value in bringing clinical skills and perspectives into the research world, and we support clinicians to launch and progress research careers.

10 August 2016

• For Researchers

Biotherapeutics: Where next for cancer immunotherapy?

We're driving discovery research in immuno-oncology which is leading to novel and exciting immunotherapeutic possibilities. We're driving discovery research in immuno-oncology which is leading to novel and exciting immunotherapeutic possibilities.

10 August 2016

• For Researchers

Health economics: the cancer drugs cost conundrum

The prices of cancer drugs have skyrocketed, increasing pressure on the NHS and sparking heated debate. Are these price tags justified and can we afford them? The prices of cancer drugs have skyrocketed, increasing pressure on the NHS and sparking heated debate. Are these price tags justified and can we afford them?

10 August 2016

• For Researchers

Team science: Solving knotty puzzles

We’re committed to helping our scientists make the connections that will stimulate their thinking. Here's how we're driving collaboration and networking. We’re committed to helping our scientists make the connections that will stimulate their thinking. Here's how we're driving collaboration and networking.

10 August 2016

• For Researchers

Why aren’t we sharing?

We caught up with three of our researchers to find out why they’ve placed data sharing at the heart of their research programmes. We caught up with three of our researchers to find out why they’ve placed data sharing at the heart of their research programmes.

10 August 2016

• For Researchers

Getting a grip on intractability

A cornerstone of our Research Strategy is to build capacity in research into cancers of unmet need, those we’ve identified due to poor five-year survival. A cornerstone of our Research Strategy is to build capacity in research into cancers of unmet need, those we’ve identified due to poor five-year survival.

10 August 2016

• For Researchers

Championing science at the heart of CRUK: Nic Jones

After five years as Cancer Research UK’s Chief Scientist, Professor Nic Jones stepped down in February 2016. After five years as Cancer Research UK’s Chief Scientist, Professor Nic Jones stepped down in February 2016.

10 August 2016

• For Researchers

Recognising excellence: CRUK prizewinners

Our awards support and celebrate the incredible work, dedication and scientific innovation of those at the forefront of advancing our ability to defeat cancer. Our awards support and celebrate the incredible work, dedication and scientific innovation of those at the forefront of advancing our ability to defeat cancer.

10 August 2016

• For Researchers

Translating great science towards patient benefit

Our commercialisation arm, Cancer Research Technology, gets innovative new treatments and tests to patients as quickly as possible. Our commercialisation arm, Cancer Research Technology, gets innovative new treatments and tests to patients as quickly as possible.

10 August 2016

• For Researchers

Achieving more through working in partnership

Developing partnerships and working collaboratively are underlying principles of our Research Strategy and is necessary in the global fight against cancer. Developing partnerships and working collaboratively are underlying principles of our Research Strategy and is necessary in the global fight against cancer.

10 August 2016

• For Researchers

A celebrated career in DNA repair: Tomas Lindahl

We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this. We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.

10 August 2016

• For Researchers

Coming home to the UK: an interview with Richard Gilbertson

One of the world’s leading experts in childhood brain tumours, Richard has led international efforts that have dramatically advanced knowledge of their biology. One of the world’s leading experts in childhood brain tumours, Richard has led international efforts that have dramatically advanced knowledge of their biology.

10 August 2016